Ac(1)-Tyr-His-Ile-Tyr-Tyr-Ala-Ser-Leu-Tyr-Gly-Asp-Leu-Gly-Cys(1)-Gly-NH2 contains multiple tyrosine residues providing aromatic and redox-active sites. The N-terminal acetyl and C-terminal amide enhance structural stability and reduce terminal charge. A single cysteine supports disulfide or thiol-based conjugation studies. Researchers use the peptide in receptor-binding, phosphorylation, and oxidative-modification models.
CAT No: R2558
CAS No:2983116-47-6
Synonyms/Alias:Lib2-1;CHEMBL5414591;2983116-47-6;HY-P5963;BDBM50627310;DA-54908;CS-0898643;
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.